Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.82 |
| ▸ | NOD1 | Q9Y239 | 13/20 | 0.72 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.56 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.56 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.56 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1043507 | 1.00 | SLC6A5 (0.82) | SLC6A5NOD1FOLH1ITGB3ITGA2B | |
| SCHEMBL4020128 | 0.98 | SLC6A5 (0.85) | SLC6A5NOD1FOLH1ITGB3ITGA2B | |
| SCHEMBL5946236 | 0.98 | SLC6A5 (0.85) | SLC6A5NOD1FOLH1ITGB3ITGA2B | |
| SCHEMBL343693 | 0.98 | SLC6A5 (0.85) | SLC6A5NOD1FOLH1ITGB3ITGA2B | |
| SCHEMBL15474 | 0.98 | SLC6A5 (0.85) | SLC6A5NOD1FOLH1ITGB3ITGA2B | |
| SCHEMBL1487710 | 0.98 | SLC6A5 (0.85) | SLC6A5NOD1FOLH1ITGB3ITGA2B | |
| SCHEMBL9716727 | 0.98 | SLC6A5 (0.85) | SLC6A5NOD1FOLH1ITGB3ITGA2B | |
| SCHEMBL1982744 | 0.98 | SLC6A5 (0.85) | SLC6A5NOD1FOLH1ITGB3ITGA2B | |
| SCHEMBL342965 | 0.98 | SLC6A5 (0.85) | SLC6A5NOD1FOLH1ITGB3ITGA2B | |
| SCHEMBL2166697 | 0.98 | SLC6A5 (0.85) | SLC6A5NOD1FOLH1ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4647059-A2 | POWDER GRANULES, AND COSMETIC PREPARATION AND CLEANSING PREPARATION | Shiseido Honeycake Industries Co., Ltd. (JP) | 2025-11-12 | — | — | EP | claimed |
| US-20250295563-A1 | Powder Granules, and Cosmetic Preparation and Cleansing Preparation | SHISEIDO HONEYCAKE INDUSTRIES CO., LTD. (JP) | 2025-09-25 | — | — | US | claimed |
| WO-2025043460-A1 | ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2025-03-06 | — | — | WO | claimed |
| CN-116234532-A | Cosmetic product | 株式会社资生堂 | 2023-06-06 | — | — | CN | claimed |
| WO-2022071135-A1 | COSMETIC | 株式会社 資生堂 | 2022-04-07 | — | — | WO | claimed |
| US-10195127-B2 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2019-02-05 | — | — | US | claimed |
| US-20100291614-A1 | IN VITRO METHOD FOR DETERMINING THE RISK OF AND DIAGNOSIS OF AN ARTERIAL VASCULAR DISORDER | SIEMENS AKTIENGESELLSCHAFT (DE) | 2010-11-18 | — | — | US | claimed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| JP-60067565-A | — | — | None | — | — | JP | disclosed |
| JP-1242517-A | — | — | None | — | — | JP | disclosed |
| US-12624395-B2 | Process for identifying a stress state and/or for assessing the stress response level in a subject | ADISSEO FRANCE S.A.S. (FR) | 2026-05-12 | — | — | US | disclosed |
| US-12533376-B2 | Prophylactic or therapeutic agent for disease induced by oxidative stress | OSAKA UNIVERSITY (JP) | 2026-01-27 | — | — | US | disclosed |
| EP-4647059-A3 | POWDER GRANULES, AND COSMETIC PREPARATION AND CLEANSING PREPARATION | Shiseido Honeycake Industries Co., Ltd. (JP) | 2026-01-14 | — | — | EP | disclosed |
| JP-H01242517-A | HAIR COSMETIC COMPOSITION | AJINOMOTO CO INC | 1989-09-27 | — | — | JP | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0178911-A2 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1986-04-23 | — | — | EP | disclosed |
| EP-0173960-A2 | Muramylpeptide active ester derivatives | Hamaoka, Toshiyuki (JP) | 1986-03-12 | — | — | EP | disclosed |
| EP-0139481-A2 | Surface modification using N-acyl lysines | AJINOMOTO CO., INC. (JP) | 1985-05-02 | — | — | EP | disclosed |
| JP-S6067565-A | AGENT FOR MODIFYING SURFACE OF INORGANIC MATERIAL | AJINOMOTO CO INC | 1985-04-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624395-B2 | Process for identifying a stress state and/or for assessing the stress response level in a subject | ANXA4, ANXA1, ANXA2 | SLC6A5 4387/4885NOD1 3015/4885FOLH1 1226/4885 |
| US-12533376-B2 | Prophylactic or therapeutic agent for disease induced by oxidative stress | LPO, SI, TNF | SLC6A5 496/4885NOD1 1874/4885FOLH1 4482/4885 |
| US-20250295563-A1 | Powder Granules, and Cosmetic Preparation and Cleansing Preparation | CUTA, PLOD1, CAPG | SLC6A5 3234/4885NOD1 3168/4885FOLH1 3594/4885 |
| US-10195127-B2 | Cosmetic composition | CUTA, H1-0, AADAT | SLC6A5 2031/4885NOD1 4769/4885FOLH1 2183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.